Click to Cancel Consumer Protection Act of 2025

Senate Bill

S. 2254

119th Congress

Click to Cancel Consumer Protection Act of 2025

In Committee

Introduced:Jul 10, 2025

Primary Sponsor

Ruben Gallego

Senator

Democratic

AZ

Cosponsors

3

Quick Stats

Policy Area

Health

Summary

This bill requires pharmacy benefit managers (PBMs) who work with Medicare drug plans to report more detailed information about the costs and pricing of prescription drugs. It aims to increase transparency and accountability around how PBMs operate in the Medicare system.

Latest Action

Read twice and referred to the Committee on Finance.

SponsorRuben Gallego (D-AZ)

Introduced7/10/2025

StatusRead twice and referred to the Committee on Commerce, Science, and Transportation.

ChamberSenate

Data from Congress.gov

See this page through your district lens

Enter ZIP to personalize representatives and vote context.

Stay on top of this issue

Subscribe for weekly bill and representative updates.

Vote Prediction

Click to Cancel Consumer Protection Act of 2025

This bill requires pharmacy benefit managers (PBMs) who work with Medicare drug plans to report more detailed information about the costs and pricing of prescription drugs. It aims to increase transparency and accountability around how PBMs operate in the Medi

Community Breakdown

Pass

0%

Fail

0%

0 predictions

This bill requires pharmacy benefit managers (PBMs) who work with Medicare drug plans to report more detailed information about the costs and pricing of prescription drugs. It aims to increase transparency and accountability around how PBMs operate in the Medicare system.

Bill Number: 2254
Sponsor: Ruben Gallego (D-AZ)
Introduced: 7/10/2025
Status: Read twice and referred to the Committee on Commerce, Science, and Transportation.
Policy Area: Health

Data from Congress.gov

AI-generated summary

Fact Sheet

Title: Click to Cancel Consumer Protection Act of 2025
Bill Number: 2254
Sponsor: Ruben Gallego (D-AZ)
Status: Read twice and referred to the Committee on Commerce, Science, and Transportation.
Introduced: 7/10/2025
Summary: This bill requires pharmacy benefit managers (PBMs) who work with Medicare drug plans to report more detailed information about the costs and pricing of prescription drugs. It aims to increase transparency and accountability around how PBMs operate in the Medicare system.

Data from Congress.gov

AI Summary

Plain-English explanation of this bill

This bill requires pharmacy benefit managers (PBMs) who work with Medicare drug plans to report more detailed information about the costs and pricing of prescription drugs. It aims to increase transparency and accountability around how PBMs operate in the Medicare system.

Last updated: 12/30/2025

Official Summary

Congressional Research Service summary

Medicare PBM Accountability ActThis bill establishes reporting requirements for pharmacy benefit managers (PBMs) under the Medicare prescription drug benefit and Medicare Advantage, particularly relating to the prices of prescription drugs.Specifically, PBMs must (1) disclose certain information underlying cost performance measurements (e.g., exclusions and terms), and (2) report to prescription drug plan (PDP) sponsors (and to the Centers for Medicare & Medicaid Services upon request) an itemized list of prescription drugs that were dispensed during the previous year and related data about costs, claims, affiliated pharmacies, and other specified information. PDP sponsors may audit PBMs to ensure compliance with this bill's requirements and must annually certify their compliance; PBMs are responsible for any associated civil penalties for violations.In addition, the Government Accountability Office must study federal and state reporting requirements for health plans and PBMs with respect to prescription drug price transparency and recommend ways to streamline these requirements.

Key Points

Main provisions of the bill

PBMs must disclose more details about how they calculate drug costs and prices for Medicare drug plans
PBMs must provide an itemized list of all drugs dispensed, their costs, and other related data to the Medicare agency and plan sponsors
Medicare drug plan sponsors can audit PBMs to ensure they are following the new reporting requirements, and PBMs face penalties for violations

How This Impacts Americans

Potential effects on citizens and communities

This bill would affect Medicare beneficiaries by potentially providing them and their drug plans with more information about the costs of their prescriptions. It could also impact PBMs, who would need to devote resources to complying with the new reporting rules. Overall, the goal is to shed light on the role of PBMs in Medicare drug pricing and potentially lead to lower costs for patients.

Policy Areas

Primary Policy Area

Health

Related Subjects

Accounting and auditing

Congressional oversight

Contracts and agency

Drug safety, medical device, and laboratory regulation

Government information and archives

Government studies and investigations

Health care costs and insurance

Prescription drugs

Retail and wholesale trades

Scope & Jurisdiction

Jurisdiction Level

federal

Congressional Session

119th Congress

Citation Reference

2254, 119th Congress (2025). "Click to Cancel Consumer Protection Act of 2025". Source: Voter's Right Platform. https://votersright.org/bills/118-s-2254